Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Flavoxine Addresses Multiple Risk Factors of Heart Health - Nutraceuticals World

What are you searching for?

Sign in
Research

Flavoxine Addresses Multiple Risk Factors of Heart Health

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Next Pharmaceuticals has released the results of a clinical trial on its new patented heart health ingredient Flavoxine. The principal investigator for the trial was Dr. Julius Oben, head of the department of biochemistry, University of Yaounde in Cameroon. The double-blind placebo-controlled clinical trial with 80 subjects showed that Flavoxine significantly increased HDL-cholesterol, the so-called “good” cholesterol, while significantly reducing LDL-cholesterol, the so-called “bad” cholesterol, and triglycerides. In addition, Flavoxine significantly reduced C-reactive protein (CRP), an indicator of inflammation that is now considered to be another positive risk factor for coronary artery disease, and it significantly lowered blood pressure and fasting blood glucose in the overweight individuals with elevated cholesterol levels.

Flavoxine is a blend of two plant extracts, a proprietary extract of Phellodendron amurense and a patented (U.S. Patent No. 6,987,125) extract of orange peel containing polymethoxylated flavones.

Next Pharmaceuticals is seeking to replicate the trial in the U.S., through a joint effort with an academic institution under a National Institutes of Health (NIH) grant.

For further information: 415-454-2243.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics